| OPERATING ACTIVITIES: | |
| Net earnings including noncontrolling interests | 823.1M |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |
| Depreciation and amortization | 318.1M |
| Provision for impairments and asset disposals | |
| Deferred income taxes, net | -6.9M |
| Equity in income of investees | |
| Distributions of income from equity investees | |
| Stock-based compensation | 70.9M |
| Tax benefit from exercise of stock options | |
| Excess tax benefit from exercise of stock options | |
| Other | 11.2M |
| Cash provided/(used) by changes in operating assets and liabilities: | |
| Inventories | 138.6M |
| Accounts payable | -37.2M |
| Accrued taxes | |
| Deferred revenue | 154M |
| Other operating assets | |
| Other operating liabilities | |
| Net cash provided by operating activities | 1.37B |
| INVESTING ACTIVITIES: | |
| Purchase of available-for-sale securities | |
| Maturities and calls of available-for-sale securities | |
| Acquisitions, net of cash acquired | -568.8M |
| Net purchases of equity, other investments and other assets | |
| Additions to property, plant and equipment, net | -484.9M |
| Net cash used by investing activities | -613M |
| FINANCING ACTIVITIES: | |
| Purchase of noncontrolling interest | |
| Proceeds from issuance of common stock | 141M |
| Excess tax benefit from exercise of stock options | 193.2M |
| Principal payments on long-term debt | -35.2M |
| Cash dividends paid | -313.5M |
| Repurchase of common stock | -588.1M |
| Other | 4M |
| Net cash used by financing activities | -718.5M |
| Effect of exchange rate changes on cash and cash equivalents | -6.4M |
| Net increase in cash and cash equivalents | 34.6M |
| CASH AND CASH EQUIVALENTS: | |
| Beginning of period | 1.19B |
| End of period | 1.22B |
| Cash paid during the period for: | |
| Interest, net of capitalized interest | 17.2M |
| Income taxes | 238.1M |